Open access · CC-BY
via OpenAlex
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Kevin J. Barnham, Ashley I. Bush
Chemical Society Reviews · 2014 · ▲ 486 citations
Abstract
Multiple abnormalities occur in the homeostasis of essential endogenous brain biometals in age-related neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. As a result, metals both accumulate in microscopic proteinopathies, and can be deficient in cells or cellular compartments. Therefore, bulk measurement of metal content in brain tissue samples reveal only the "tip of the iceberg", with most of the important changes occurring on a microscopic and biochemical level. Each of the major proteins implicated in these disorders interacts with biological transition metals. Tau and the amyloid protein precursor have important roles in normal neuronal iron homeostasis. Changes in metal distribution, cellular deficiencies, or sequestration in proteinopathies all present abnormalities that can be corrected in animal models by small molecules. These biochemical targets are more complex than the simple excess of metals that are targeted by chelators. In this review we illustrate some of the richness in the science that has developed in the study of metals in neurodegeneration, and explore its novel pharmacology.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1039/c4cs00138a
- Canonical
- link ↗
- Fetched
- 2026-06-03 MST
Cite this
APA
Barnham, K.J., & Bush, A.I. (2014). Biological metals and metal-targeting compounds in major neurodegenerative diseases. <em>Chemical Society Reviews</em>. https://doi.org/10.1039/c4cs00138a
Vancouver
Barnham KJ, Bush AI. Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chemical Society Reviews. 2014. doi:10.1039/c4cs00138a.
BibTeX
@article{kevin2014Biolog,
title = {Biological metals and metal-targeting compounds in major neurodegenerative diseases},
author = {Kevin J. Barnham and Ashley I. Bush},
journal = {Chemical Society Reviews},
year = {2014},
doi = {10.1039/c4cs00138a},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neural Regeneration Research 2025
Open access · CC-BY
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer’s disease
Neural regeneration research 2026
Open access · OA
Targeting innovative therapeutic approaches to the hallmarks of aging to combat Alzheimer's disease.
Cells 2020
Open access · CC-BY
Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Annual Review of Medicine 2017
Open access · OA
Innate Immunity and Neurodegeneration
Neural Regeneration Research 2023
Open access · CC-BY
Mitophagy in neurodegenerative disease pathogenesis
European Journal of Neuroscience 2026
Open access · OA